Clinical Trial Update: Supplemental Benefit of Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the supplemental benefit of the angiotensin receptor blocker olmesartan in hypertensive patients with stable heart failure; the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• Olmesartan (olmesartan)

Snippet

Sponsor: Tohoku University | Conditions: Chronic Heart Failure | Phase 3 | Status: COMPLETED